Skip to content

Prediction of bleeding and prognosis of patients with liver cirrhosis using thromboelastography

Evaluation of thromboelastography in patients with liver cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003621
Enrollment
300
Registered
2019-03-13
Start date
2018-09-13
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Anam Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who meet the criteria for diagnosis of liver cirrhosis from 19 to 80 years of age. 1) Histologically diagnosed cirrhosis 2) If there is evidence of cirrhosis on imaging findings and one of the following is satisfied a. Platelet count 12cm c. presence of varix or ascites 2. Patients who agree to check for conventional coagulation tests and thromboelastography.

Exclusion criteria

Exclusion criteria: 1. Patients with hepatocellular carcinoma. 2. Patients who received liver transplants prior to enrollment. 3. Patients with coagulation disorders due to other diseases or conditions other than cirrhosis (ex: vWF disease, hemophilia, AF, thrombophilia, pregnancy, etc.). 4. Patients who did not agree to enroll. 5. Patients taking anticoagulation. (If the drug can be withdrawn, it can be enrolled after 2 weeks or more after the interruption)

Design outcomes

Primary

MeasureTime frame
Varix bleeding occurrence;Mortality and urgent liver transplantation

Secondary

MeasureTime frame
Bleeding occurrence other than varix bleeding;Cirrhosis complication development

Countries

Korea, Republic of

Contacts

Public ContactTaeHyung Kim

Korea University Anam Hospital

lacid81@gmail.com+82-2-920-6555

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026